We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » FDA to Address ‘Narrow’ Labeling of In Vitro Companion Devices for Cancer Drugs
FDA to Address ‘Narrow’ Labeling of In Vitro Companion Devices for Cancer Drugs
The way in vitro companion diagnostics for cancer drugs are labeled sometimes presents a challenge for oncology care, Commissioner Scott Gottlieb said Thursday in announcing new guidance to tackle the problem.